melanoma

Roche immunotherapy shows response over range of cancers

Roche immunotherapy shows response over range of cancers

Reuters

Bristol-Myers Drug Cocktail Stymies Melanoma Tumors

Bristol-Myers Drug Cocktail Stymies Melanoma Tumors

Bloomberg

Bristol-Myers Sues Genentech Over ‘Cabilly’ Patents

Bristol-Myers Sues Genentech Over ‘Cabilly’ Patents

Bloomberg

Bristol-Myers Has The Future Of Oncology Therapies

Bristol-Myers Has The Future Of Oncology Therapies

Seeking Alpha

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial

Seeking Alpha

Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy

Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy

Yahoo/AP

Melanoma: Battle Of 3 Cancer Vaccines

Melanoma: Battle Of 3 Cancer Vaccines

Seeking Alpha

Array's Up-Coming Value Enhancing Catalysts

Array's Up-Coming Value Enhancing Catalysts

Seeking Alpha

Yervoy-Zelboraf combo trial stopped on toxicity worries

Yervoy-Zelboraf combo trial stopped on toxicity worries

Fierce Pharma

Amgen's And Vical's Melanoma Trials: Questions

Amgen's And Vical's Melanoma Trials: Questions

Seeking Alpha